acyclovir
Generic: acyclovir
Labeler: bryant ranch prepackDrug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
bryant ranch prepack
Dosage Form
TABLET
Routes
Active Ingredients
acyclovir 400 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71335-1645
Product ID
71335-1645_66494894-8469-4633-ba3e-2b02aa2aa4eb
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA074891
Listing Expiration
2026-12-31
Marketing Start
2013-08-08
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
713351645
Hyphenated Format
71335-1645
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA074891 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 400 mg/1
Packaging
- 120 TABLET in 1 BOTTLE (71335-1645-0)
- 20 TABLET in 1 BOTTLE (71335-1645-1)
- 28 TABLET in 1 BOTTLE (71335-1645-2)
- 30 TABLET in 1 BOTTLE (71335-1645-3)
- 50 TABLET in 1 BOTTLE (71335-1645-4)
- 15 TABLET in 1 BOTTLE (71335-1645-5)
- 60 TABLET in 1 BOTTLE (71335-1645-6)
- 25 TABLET in 1 BOTTLE (71335-1645-7)
- 10 TABLET in 1 BOTTLE (71335-1645-8)
- 40 TABLET in 1 BOTTLE (71335-1645-9)
Packages (10)
71335-1645-0
120 TABLET in 1 BOTTLE (71335-1645-0)
71335-1645-1
20 TABLET in 1 BOTTLE (71335-1645-1)
71335-1645-2
28 TABLET in 1 BOTTLE (71335-1645-2)
71335-1645-3
30 TABLET in 1 BOTTLE (71335-1645-3)
71335-1645-4
50 TABLET in 1 BOTTLE (71335-1645-4)
71335-1645-5
15 TABLET in 1 BOTTLE (71335-1645-5)
71335-1645-6
60 TABLET in 1 BOTTLE (71335-1645-6)
71335-1645-7
25 TABLET in 1 BOTTLE (71335-1645-7)
71335-1645-8
10 TABLET in 1 BOTTLE (71335-1645-8)
71335-1645-9
40 TABLET in 1 BOTTLE (71335-1645-9)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "66494894-8469-4633-ba3e-2b02aa2aa4eb", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197311"], "spl_set_id": ["331fe0bd-6bb2-4337-8faa-d0c82ff54dc7"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (71335-1645-0)", "package_ndc": "71335-1645-0", "marketing_start_date": "20200709"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (71335-1645-1)", "package_ndc": "71335-1645-1", "marketing_start_date": "20200702"}, {"sample": false, "description": "28 TABLET in 1 BOTTLE (71335-1645-2)", "package_ndc": "71335-1645-2", "marketing_start_date": "20220128"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (71335-1645-3)", "package_ndc": "71335-1645-3", "marketing_start_date": "20200625"}, {"sample": false, "description": "50 TABLET in 1 BOTTLE (71335-1645-4)", "package_ndc": "71335-1645-4", "marketing_start_date": "20220128"}, {"sample": false, "description": "15 TABLET in 1 BOTTLE (71335-1645-5)", "package_ndc": "71335-1645-5", "marketing_start_date": "20220128"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (71335-1645-6)", "package_ndc": "71335-1645-6", "marketing_start_date": "20200923"}, {"sample": false, "description": "25 TABLET in 1 BOTTLE (71335-1645-7)", "package_ndc": "71335-1645-7", "marketing_start_date": "20201218"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (71335-1645-8)", "package_ndc": "71335-1645-8", "marketing_start_date": "20201223"}, {"sample": false, "description": "40 TABLET in 1 BOTTLE (71335-1645-9)", "package_ndc": "71335-1645-9", "marketing_start_date": "20220128"}], "brand_name": "ACYCLOVIR", "product_id": "71335-1645_66494894-8469-4633-ba3e-2b02aa2aa4eb", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "71335-1645", "generic_name": "ACYCLOVIR", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ACYCLOVIR", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "400 mg/1"}], "application_number": "ANDA074891", "marketing_category": "ANDA", "marketing_start_date": "20130808", "listing_expiration_date": "20261231"}